ViaCell About
ViaCell ViaCell,
Inc. (Nasdaq: VIAC),is a clinical-stage biotechnology company dedicated to enabling
the widespread application of human cells as medicine in the areas of cancer,
cardiac disease, diabetes and infertility. A proprietary, highly expanded population
of stem and progenitor cells, CB001 is currently being studied in a clinical trial
as a substitute for bone marrow and other hematopoietic stem cell transplants. Viacord
for Pediatric hematopoietic stem
cell transplantation -- Marketed Hematopoietic (CB001) --Hematopoietic
stem
cell transplantation --Clinical Trials More
on
ViaCell